Awareness, Care & Treatment In Obesity Management - An International Observation

NCT03584191 | Completed

• 2 other identifiers: NN8022-4449U1111-1209-6406
• Study Type: observational
• Target: 17,287
• Locations: 9 countries
• Sites: 9

Brief Summary

The purpose of this survey is to collect the data on perceptions, behaviours and awareness related to obesity and obesity management for People with Obesity (PwO) and Health Care Professionals (HCP) treating obesity. Data will be collected via online surveys among each of the respondent groups. The surveys are expected to take approximately 25 minutes to complete and will be unique for PwO and HCP. As a cross-sectional study, there will be no treatment of patients.

Conditions

Obesity

Outcome Measures

Primary Outcomes (9)

• Weight loss motivators

  Online questionnaire - Multiple Item Selection

  Start of interviews day 1 until end of data collection day 90

• Proportion of PwO / patients who made serious weight loss effort

  Online questionnaire - Numeric Response

  Start of interviews day 1 until end of data collection day 90

• Response to weight loss discussions

  Online questionnaire - Single Item Selection

  Start of interviews day 1 until end of data collection day 90

• Effective weight loss methods

  Online questionnaire - Multiple Item Selection

  Start of interviews day 1 until end of data collection day 90

• Obesity attitudes

  Online questionnaire - End-anchored 5-point Likert agreement scale (from "1", do not agree at all, to "5" completely agree)

  Start of interviews day 1 until end of data collection day 90

• Attitudes toward prescription weight loss medication and surgery

  Online questionnaire - End-anchored 5-point Likert agreement scale (from "1", do not agree at all, to "5" completely agree)

  Start of interviews day 1 until end of data collection day 90

• Weight loss barriers

  Online questionnaire - End-anchored 5-point Likert agreement scale(from "1", do not agree at all, to "5" completely agree)

  Start of interviews day 1 until end of data collection day 90

• Obesity and weight management

  Online questionnaire - End-anchored 5-point Likert agreement scale(from "1", do not agree at all, to "5" completely agree)

  Start of interviews day 1 until end of data collection day 90

• Degree to which healthcare and society is meeting needs of people with obesity

  Online questionnaire - End-anchored 5-point Likert needs scale(from "1", do not agree at all, to "5" completely agree)

  Start of interviews day 1 until end of data collection day 90

Secondary Outcomes (7)

• Top factors for improving weight loss outcomes

  Start of interviews day 1 until end of data collection day 90

• Types of weight management goals

  Start of interviews day 1 until end of data collection day 90

• Most helpful information for patients for weight loss

  Start of interviews day 1 until end of data collection day 90

• Responsibility for improving health of people with obesity

  Start of interviews day 1 until end of data collection day 90

• Most helpful support for weight loss

  Start of interviews day 1 until end of data collection day 90

Study Arms (2)

People with Obesity

General population - potential participants will be recruited using various and numerous general population as appropriate in each country.

Other: No treatment given

Health Care Professionals

Health Care Professionals include primary care physicians and specialists who treat patients with obesity.

Other: No treatment given

Interventions

No treatment given OTHER

Completion of a survey

Health Care Professionals; People with Obesity

Eligibility Criteria

• Sex: all
• Healthy Volunteers: No
• Age Groups: Child (0-17), Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

Patients with obesity and health care professionals

Sponsors & Collaborators

• Novo Nordisk A/S: lead

Study Sites (9)

Novo Nordisk Investigational Site

Baulkham Hills, New South Wales, 2153, Australia

Location

Novo Nordisk Investigational Site

Kfar Saba, 44425, Israel

Location

Novo Nordisk Investigational Site

Polanco, Mexico

Location

Novo Nordisk Investigational Site

Riyadh, 3542, Saudi Arabia

Location

Novo Nordisk Investigational Site

Seoul, South Korea

Location

Novo Nordisk Investigational Site

Madrid, 28033, Spain

Location

Novo Nordisk Investigational Site

Zurich, Switzerland

Location

Novo Nordisk Investigational Site

Dubai, United Arab Emirates

Location

Novo Nordisk Investigational Site

Gatwick, United Kingdom

Location

Related Publications (7)

• Caterson ID, Alfadda AA, Auerbach P, Coutinho W, Cuevas A, Dicker D, Hughes C, Iwabu M, Kang JH, Nawar R, Reynoso R, Rhee N, Rigas G, Salvador J, Sbraccia P, Vazquez-Velazquez V, Halford JCG. Gaps to bridge: Misalignment between perception, reality and actions in obesity. Diabetes Obes Metab. 2019 Aug;21(8):1914-1924. doi: 10.1111/dom.13752. Epub 2019 May 3.

  PMID: 31032548 RESULT

• Hughes CA, Ahern AL, Kasetty H, McGowan BM, Parretti HM, Vincent A, Halford JCG. Changing the narrative around obesity in the UK: a survey of people with obesity and healthcare professionals from the ACTION-IO study. BMJ Open. 2021 Jun 30;11(6):e045616. doi: 10.1136/bmjopen-2020-045616.

  PMID: 34193488 DERIVED

• Dicker D, Alfadda AA, Coutinho W, Cuevas A, Halford JCG, Hughes CA, Iwabu M, Kang JH, Nawar R, Reynoso R, Rhee N, Rigas G, Salvador J, Sbraccia P, Vazquez-Velazquez V, Caterson ID. Patient motivation to lose weight: Importance of healthcare professional support, goals and self-efficacy. Eur J Intern Med. 2021 Sep;91:10-16. doi: 10.1016/j.ejim.2021.01.019. Epub 2021 Feb 6.

  PMID: 33558163 DERIVED

• Alfadda AA, Caterson ID, Coutinho W, Cuevas A, Dicker D, Halford JCG, Hughes CA, Iwabu M, Kang JH, Nawar R, Reynoso R, Rhee N, Rigas G, Salvador J, Vazquez-Velazquez V, Sbraccia P. The 3Ds - Discussion, diagnosis and direction: Elements for effective obesity care by healthcare professionals. Eur J Intern Med. 2021 Sep;91:17-25. doi: 10.1016/j.ejim.2021.01.012. Epub 2021 Jan 23.

  PMID: 33495083 DERIVED

• Vazquez-Velazquez V, Laviada-Molina H, Garcia-Garcia E, Sandoval-Diez E, Mancillas-Adame L. Perceptions, Attitudes, and Barriers to Obesity Care in Mexico: Data From the ACTION-IO Study. Obesity (Silver Spring). 2021 Feb;29(2):317-326. doi: 10.1002/oby.23077.

  PMID: 33491317 DERIVED

• Dicker D, Kornboim B, Bachrach R, Shehadeh N, Potesman-Yona S, Segal-Lieberman G. ACTION-IO as a platform to understand differences in perceptions, attitudes, and behaviors of people with obesity and physicians across countries - the Israeli experience. Isr J Health Policy Res. 2020 Oct 21;9(1):56. doi: 10.1186/s13584-020-00404-2.

  PMID: 33087177 DERIVED

• Sbraccia P, Busetto L, Santini F, Mancuso M, Nicoziani P, Nicolucci A. Misperceptions and barriers to obesity management: Italian data from the ACTION-IO study. Eat Weight Disord. 2021 Apr;26(3):817-828. doi: 10.1007/s40519-020-00907-6. Epub 2020 May 8.

  PMID: 32385580 DERIVED

MeSH Terms

Conditions

Obesity

Condition Hierarchy (Ancestors)

Overweight; Overnutrition; Nutrition Disorders; Nutritional and Metabolic Diseases; Body Weight; Signs and Symptoms; Pathological Conditions, Signs and Symptoms

Study Officials

• Clinical Reporting Anchor and Disclosure (1452)

  Novo Nordisk A/S

  STUDY DIRECTOR

Study Design

• Study Type: observational
• Observational Model: ECOLOGIC OR COMMUNITY
• Time Perspective: CROSS SECTIONAL
• Sponsor Type: INDUSTRY
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: June 29, 2018
• First Posted: July 12, 2018
• Study Start: June 4, 2018
• Primary Completion: October 10, 2018
• Study Completion: October 10, 2018
• Last Updated: May 24, 2019

Record last verified: 2019-05

Data Sharing

• IPD Sharing: Will share

Locations

ME (1); AU (1); ES (1); CH (1); KR (1); IL (1); SA (1); GB (1); AE (1)